I agree that this site is using cookies. You can find further informations here.
X
Poklepovic, Andrew S.
85  results:
Search for persons X
?
1

Delayed Postoperative Intracerebral Hemorrhage Associated W..:

Patel, Vishal C ; Krishnakumar, Asha ; Yang, Edward H..
Cureus.  , 2024
Link: https://doi.org/10.7759/..
 
?
2

US physician perspective on the use of biomarker and ctDNA ..:

Fischer, Rachel A. ; Ryan, Isabel ; De La Torre, Kristine...
Critical Reviews in Oncology/Hematology.  196 (2024)  - p. 104289 , 2024
Link: https://doi.org/10.1016/..
 
?
3

A phase 1 study of regorafenib and sildenafil in adults wit..:

Poklepovic, Andrew S. ; Gordon, Sarah W. ; Kothadia, Sejal...
Anti-Cancer Drugs.  35 (2024)  5 - p. 450-458 , 2024
Link: https://doi.org/10.1097/..
 
?
4

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in ..:

Cohen, Stacey A. ; Kasi, Anup ; Hook, Nicole...
Case Reports in Obstetrics and Gynecology.  2022 (2022)  - p. 1-5 , 2022
Link: https://doi.org/10.1155/..
 
?
5

Immunologically programming the tumor microenvironment indu..:

Yu, Xiaofei ; Liu, Wenjie ; Chen, Shixian...
Journal for ImmunoTherapy of Cancer.  9 (2021)  1 - p. e001595 , 2021
Link: https://doi.org/10.1136/..
 
?
6

A multi‐institutional phase 2 trial of regorafenib in refra..:

Kim, Richard D. ; Sanoff, Hanna K. ; Poklepovic, Andrew S....
Cancer.  126 (2020)  15 - p. 3464-3470 , 2020
Link: https://doi.org/10.1002/..
 
?
7

Considering adjuvant therapy for stage II melanoma:

Poklepovic, Andrew S. ; Luke, Jason J.
Cancer.  126 (2019)  6 - p. 1166-1174 , 2019
Link: https://doi.org/10.1002/..
 
?
8

BMI, irAE, and gene expression signatures associate with re..:

Labadie, Brian W. ; Liu, Ping ; Bao, Riyue...
Journal of Translational Medicine.  17 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
9

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Adva..:

Patel, Sapna P ; Othus, Megan ; Chen, Yuanbin...
qt87x612c2.  , 2023
Link: https://escholarship.org..
 
?
10

Immunologically programming the tumor microenvironment indu..:

Yu, Xiaofei ; Liu, Wenjie ; Chen, Shixian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817794/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

A Multi-Institutional Phase 2 Trial of Regorafenib in Refra..:

Kim, Richard D ; Sanoff, Hanna K ; Poklepovic, Andrew S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787270/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

Considering adjuvant therapy for stage II melanoma:

Poklepovic, Andrew S ; Luke, Jason J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065103/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
13

Pembrolizumab versus placebo as adjuvant therapy in complet..:

Luke, Jason J ; Rutkowski, Piotr ; Queirolo, Paola...
The Lancet.  399 (2022)  10336 - p. 1718-1729 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Correction: HDAC inhibitors enhance neratinib activity and ..:

Booth, Laurence ; Roberts, Jane L. ; Poklepovic, Andrew...
Oncotarget.  10 (2019)  49 - p. 5120-5122 , 2019
Link: https://doi.org/10.18632..
 
?
15

Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RA..:

Dent, Paul ; Booth, Laurence ; Roberts, Jane L....
Oncogene.  38 (2019)  30 - p. 5890-5904 , 2019
Link: https://doi.org/10.1038/..
 
1-15